Solentim Ltd., headquartered in Great Britain, is a pioneering company in the life sciences sector, specialising in advanced cell line development and high-throughput screening technologies. Founded in 2014, Solentim has quickly established itself as a leader in the biopharmaceutical industry, providing innovative solutions that enhance the efficiency and accuracy of cell culture processes. The company’s flagship products, including the Cell Line Development System and the Vial-to-Cell technology, are designed to streamline workflows and improve productivity for researchers and manufacturers alike. Solentim's commitment to quality and innovation has earned it a strong market position, with notable achievements in accelerating drug development timelines and optimising bioprocessing. With a focus on customer-centric solutions, Solentim continues to drive advancements in cell-based therapies and biomanufacturing.
We don't have data for Solentim Ltd., but we can show you information about their parent organization instead.
View parent company